Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
08/23/2011 | US8005622 Computerized system and method for safely transfusing blood products |
08/23/2011 | US8005621 Transcript mapping method |
08/23/2011 | US8005620 Systems and methods for biopolymer engineering |
08/23/2011 | US8003847 Animal models comprising mutation in opoid receptor for use in identifying modulator for prevention and treatment of cell proliferative, nervous system and psychological disorders |
08/23/2011 | US8003776 Mycobacterial antigens expressed during latency |
08/23/2011 | US8003767 Sulfonated [8,9]benzophenoxazine dyes and the use of their labelled conjugates |
08/23/2011 | US8003765 Lipocalin-type prostaglandin D2 synthase specific monoclonal antibody for use in diagnosis of nervous system trauma and dysfunction |
08/23/2011 | US8003764 Folliculin-specific antibodies and methods of detection |
08/23/2011 | US8003763 for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; bind Cripto and block the interaction between Cripto and activin-like kinase (ALK) 4 |
08/23/2011 | US8003758 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
08/23/2011 | US8003757 Receptor-based interaction trap |
08/23/2011 | US8003753 Fret protease assays for clostridial toxins |
08/23/2011 | US8003621 Drug carriers |
08/23/2011 | US8003409 Semiconductor nanoparticle fluorescent reagent and fluorescence determination method |
08/23/2011 | US8003408 Modification of metal nanoparticles for improved analyte detection by surface enhanced Raman spectroscopy (SERS) |
08/23/2011 | US8003407 Lateral flow system and assay |
08/23/2011 | US8003406 Methods for detecting attention-deficit/hyperactivity disorder |
08/23/2011 | US8003402 Method for measuring the concentration of a glycosaminoglycan anticoagulant |
08/23/2011 | US8003401 Carbon dioxide sensor and method of determining partial pressure of carbon dioxide |
08/23/2011 | US8003400 Measurement of vitamin D |
08/23/2011 | US8003399 Nitrite detection technique |
08/23/2011 | US8003398 Determining the presence or amount of glyphosate, N-acetylglyphosate, N-acetyl AMPA or aminomethyl phosphoric acid (AMPA) |
08/23/2011 | US8003397 Glucose monitoring by viscometric sensing of polymeric fluid |
08/23/2011 | US8003396 NT-proBNP/troponin ratio for assessing myocardial dysfunction |
08/23/2011 | US8003395 Non-signal imidazole reagents for mass spectrometry analysis of phosphomonoesters |
08/23/2011 | US8003394 Methods for metal assays using optical techniques |
08/23/2011 | US8003393 Method for determining whether or not a mammal is affected with a lung cancer |
08/23/2011 | US8003392 Diagnostic test for the detection of early stage liver cancer |
08/23/2011 | US8003389 Mixture comprising mannitol for suspending animal or human cells and for dissolving biologically active molecules in order to introduce molecules into cells using electric current |
08/23/2011 | US8003382 Nucleic acid molecules encoding a house dust mite allergen Der f VII, and antigenic peptides thereof |
08/23/2011 | US8003376 Capillary array and related methods |
08/23/2011 | US8003373 Optical detector for enzyme activation |
08/23/2011 | US8003372 Device for performing cell assays |
08/23/2011 | US8003355 Polymer extraction methods |
08/23/2011 | US8003347 Nucleic acids encoding ChemerinR ligands |
08/23/2011 | US8003346 Mutant PCNA |
08/23/2011 | US8003341 Method of amplifying ATP and use thereof |
08/23/2011 | US8003340 Method and kit for isolating and fractioning phosphoproteins |
08/23/2011 | US8003339 Method for determining endoglycosidase (heparanase) enzyme activity |
08/23/2011 | US8003338 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
08/23/2011 | US8003337 Method for detecting lysosomal storage diseases |
08/23/2011 | US8003336 Method of screening endothelial cells for angiogenic capability |
08/23/2011 | US8003335 Levels of APRIL in serum and use in diagnostic methods |
08/23/2011 | US8003334 Methods for identifying compounds which bind to TANGO294 |
08/23/2011 | US8003333 Serum biomarkers for early detection of acute cellular rejection |
08/23/2011 | US8003332 Inhibition of membrane fusion proteins |
08/23/2011 | US8003331 Method for identifying target protein of drug and method for screening therapeutic agent for diabetes using the target protein |
08/23/2011 | US8003319 Systems and methods for controlling position of charged polymer inside nanopore |
08/23/2011 | US8003315 TAOJIKs as modifiers of the beta-catenin pathway and methods of use |
08/23/2011 | US8003313 Method for detecting and removing endotoxin |
08/23/2011 | US8003107 Antibodies to Lawsonia intracellularis |
08/23/2011 | US8003075 Diagnostic assay for human matrix GLA-protein and its use as a biomarker |
08/23/2011 | US8003055 Visual hydrogen detector with variable reversibility |
08/23/2011 | US8003054 Fluid analyser systems |
08/23/2011 | US8003052 Diagnostic tape cassette |
08/23/2011 | US8003050 Device for analyzing samples |
08/23/2011 | US8003048 Automated standards sampling |
08/23/2011 | US8001856 Sampling device |
08/23/2011 | CA2628891C Key for vehicle and drunken driving preventing device |
08/23/2011 | CA2583563C Diagnostic system for determining substance concentrations in liquid samples |
08/23/2011 | CA2569164C Ir-sensor, particularly a co2 sensor |
08/23/2011 | CA2488789C Model animals non-responsive to mycobacteria-origin lipoprotein/lipopeptide |
08/23/2011 | CA2473276C Method for inspecting a titanium-based component |
08/23/2011 | CA2462276C 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
08/23/2011 | CA2460801C Method for quantitative video-microscopy and associated system and computer software program product |
08/23/2011 | CA2448390C Semen analysis |
08/23/2011 | CA2412361C Toxicity typing using liver stem cells |
08/23/2011 | CA2402871C Affinity selected signature peptides for protein identification and quantification |
08/23/2011 | CA2296807C Erbb4 receptor-specific neuregulin related ligands and uses therefor |
08/23/2011 | CA2286458C Method of detecting procarboxypeptidase a and carboxypeptidase a levels in biological fluids |
08/23/2011 | CA2270877C Peptide-based immunotherapeutic agent |
08/23/2011 | CA2270176C Methylated, smd homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus |
08/23/2011 | CA1341620C Envelope antigens of hiv-1 |
08/18/2011 | WO2011100761A2 Cd4 t-cells involved in mammalian host response to epithelial cell infection and uses thereof |
08/18/2011 | WO2011100708A2 Assay card for sample acquisition, treatment and reaction |
08/18/2011 | WO2011100669A2 Lable-free multiplexing bioassays using fluorescent conjugated polymers and barcoded nanoparticles |
08/18/2011 | WO2011100639A2 Pla2activity as a marker for ovarian and other gynecologic cancers |
08/18/2011 | WO2011100638A1 Nanostructured high surface area supports for biomolecule, chemical, drug, and cell attachment applications and methods of making the same |
08/18/2011 | WO2011100637A1 Markers for determination of patient responsiveness |
08/18/2011 | WO2011100636A1 Markers for determination of patient responsiveness |
08/18/2011 | WO2011100620A2 Upar binding agents and methods of use thereof |
08/18/2011 | WO2011100595A2 Methods and devices for sample collection, treatment and dispensing |
08/18/2011 | WO2011100483A1 Salivary biomarkers for lung cancer detection |
08/18/2011 | WO2011100472A1 Salivary transcriptomic and proteomic biomarkers for breast cancer detection |
08/18/2011 | WO2011100462A1 Hyperglycosylated hcg detection device |
08/18/2011 | WO2011100458A2 Methods for fractionating and processing microparticles from biological samples and using them for biomarker discovery |
08/18/2011 | WO2011100443A1 Oligonucleotides relating to clostridium difficile genes encoding toxin b, toxin a, or binary toxin |
08/18/2011 | WO2011100435A2 Automated drilling fluid analyzer |
08/18/2011 | WO2011100426A2 Compositons and methods for predicting cardiovascular events |
08/18/2011 | WO2011100408A2 Serologic correlates of protection against bacillis anthracis infection |
08/18/2011 | WO2011100396A2 Serum clusterin levels in systemic amyloidosis featuring cardiomyopathy |
08/18/2011 | WO2011100374A2 Mediator and cohesin connect gene expression and chromatin architecture |
08/18/2011 | WO2011100358A2 Systems and methods for detecting target analytes |
08/18/2011 | WO2011100341A1 New signaling molecule involved in ultraviolet damage to skin |
08/18/2011 | WO2011100292A1 Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards |
08/18/2011 | WO2011100253A2 Carbon quantifying apparatus and method |
08/18/2011 | WO2011100192A2 Radioiodine-labeled thyroxine dosimetry, and methods of use thereof |
08/18/2011 | WO2011100057A2 Methods and compositions for universal detection of nucleic acids |
08/18/2011 | WO2011100010A2 Sensors and methods for detecting peroxide based explosives |
08/18/2011 | WO2011099985A1 Methods of normalizing measured drug concentrations and testing for non-compliance with a drug treatment regimen |